Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Please find enclosed herewith the Annual Secretarial Compliance Report for year ended March 31, 2026.
Regulatory Filings Classification · 85% confidence The document is an Annual Secretarial Compliance Report issued by the Company Secretary under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is primarily an officer’s certification/attestation of compliance rather than a substantive financial report (e.g., Annual Report, Interim Report) or an announcement of a report. Under the certification rule, such attestations are classified as Regulatory Filings (RNS).
2026-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a full transcript of the company’s Q4 & FY ’26 earnings conference call held on May 12, 2026, including moderator and management remarks, forward‐looking statements, and detailed discussion of financial results. This matches the definition of a Call Transcript (CT).
2026-05-15 English
Please find enclosed herewith the transcript of the earnings call held on May 12, 2026.
Call Transcript Classification · 95% confidence The document is a transcript of the Advanced Enzyme Technologies Ltd. conference call held on May 12, 2026, discussing quarterly and full-year audited financial results, including management remarks and Q&A format. This clearly fits the definition of a Call Transcript (CT).
2026-05-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 88% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, advising stock exchanges of the availability of an audio recording of a conference call. It contains no substantive financial data or transcript content and serves as a regulatory disclosure/announcement. Therefore, it fits the “Regulatory Filings” category (RNS).
2026-05-12 English
Please find enclosed herewith audio recording of earnings call held on May 12, 2026.
Regulatory Filings Classification · 85% confidence The document is an SEBI LODR (Regulation 30) intimation to stock exchanges notifying investors about the availability of the audio recording of the conference call and future transcript. It does not include actual financial data, nor the full call transcript, nor is it the audited report itself. It is a regulatory disclosure notice, so it should be classified under Regulatory Filings (RNS) as a miscellaneous compliance announcement.
2026-05-12 English
Copy of Newspaper Publication
Earnings Release Classification · 85% confidence The document is a letter to the stock exchanges enclosing the newspaper publication of the “Extract of Audited Consolidated Financial Results” for the quarter and year ended March 31, 2026. It contains key highlights (summary tables of total income, profit before and after tax, earnings per share) rather than full financial statements. This format corresponds to an initial earnings announcement of quarterly/periodical results, i.e., an Earnings Release. FY 2026
2026-05-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.